A Study on the Long-term Efficacy, Safety and Persistence of Immune Response of a Vaccine Against Herpes Zoster in Older Adults
Clinical trial NCT05371080 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05371080
- Sponsor
- GlaxoSmithKline
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-08-10
- Primary completion
- 2027-08-23
- Enrollment
- 3038
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.